dc.contributorUniversidade Estadual de Londrina (UEL)
dc.contributorCIPE
dc.contributorUniversidade de São Paulo (USP)
dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-27T11:29:38Z
dc.date.available2014-05-27T11:29:38Z
dc.date.created2014-05-27T11:29:38Z
dc.date.issued2013-06-01
dc.identifierInternational Journal of Molecular Sciences, v. 14, n. 6, p. 10791-10808, 2013.
dc.identifier1661-6596
dc.identifier1422-0067
dc.identifierhttp://hdl.handle.net/11449/75587
dc.identifier10.3390/ijms140610791
dc.identifierWOS:000320772500007
dc.identifier2-s2.0-84878174197
dc.identifier2-s2.0-84878174197.pdf
dc.identifier2259986546265579
dc.description.abstractPenile carcinoma (PeCa) represents an important public health problem in poor and developing countries. Despite its unpredictable behavior and aggressive treatment, there have only been a few reports regarding its molecular data, especially epigenetic mechanisms. The functional diversity in different cell types is acquired by chromatin modifications, which are established by epigenetic regulatory mechanisms involving DNA methylation, histone acetylation, and miRNAs. Recent evidence indicates that the dysregulation in these processes can result in the development of several diseases, including cancer. Epigenetic alterations, such as the methylation of CpGs islands, may reveal candidates for the development of specific markers for cancer detection, diagnosis and prognosis. There are a few reports on the epigenetic alterations in PeCa, and most of these studies have only focused on alterations in specific genes in a limited number of cases. This review aims to provide an overview of the current knowledge of the epigenetic alterations in PeCa and the promising results in this field. The identification of epigenetically altered genes in PeCa is an important step in understanding the mechanisms involved in this unexplored disease. © 2013 by the authors; licensee MDPI, Basel, Switzerland.
dc.languageeng
dc.relationInternational Journal of Molecular Sciences
dc.relation3.687
dc.relation1,260
dc.rightsAcesso aberto
dc.sourceScopus
dc.subjectDNA methylation
dc.subjectEpigenetic
dc.subjectMolecular markers
dc.subjectPenile cancer
dc.subjectcyclin dependent kinase inhibitor 2A
dc.subjectcytosine
dc.subjectDNA
dc.subjecthistone
dc.subjectmicroRNA
dc.subjectRas association domain family protein 1A
dc.subjectcancer diagnosis
dc.subjectcancer prognosis
dc.subjectcancer risk
dc.subjectcancer therapy
dc.subjectCpG island
dc.subjectepigenetics
dc.subjectEpstein Barr virus
dc.subjectEpstein Barr virus infection
dc.subjecthistopathology
dc.subjecthuman
dc.subjectlymph node dissection
dc.subjectlymph node metastasis
dc.subjectnonhuman
dc.subjectpapillomavirus infection
dc.subjectpenis carcinoma
dc.subjectprediction
dc.subjectreview
dc.subjectrisk factor
dc.subjectWart virus
dc.titleEpigenetic mechanisms in penile carcinoma
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución